{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T20:53:15Z","timestamp":1793566395841,"version":"4.5.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"36","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Non-alcoholic fatty liver disease (NAFLD) is estimated to affect approximately 25% of the global population. Both, coronary artery disease and NAFLD are linked to underlying insulin resistance and inflammation as drivers of the disease. Coronary flow reserve parameters, including coronary flow reserve velocity (CFRV), baseline diastolic peak flow velocity (DPFV), and hyperemic DPFV, are noninvasive markers of coronary microvascular circulation. The existing literature contains conflicting findings regarding these parameters in NAFLD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A comprehensive systematic search was conducted on major electronic databases from inception until May 8, 2024, to identify relevant studies. We pooled the standardized mean differences (SMD) with 95% confidence intervals (CI) using the inverse-variance random-effects model. Statistical significance was set at <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Four studies with 1139 participants (226 with NAFLD and 913 as controls) were included. NAFLD was associated with a significantly lower CFRV (SMD: \u22120.77; 95% CI: \u22121.19, \u22120.36; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0002) and hyperemic DPFV (SMD: \u22120.73; 95% CI: \u22121.03, \u22120.44; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.00001) than the controls. NAFLD demonstrated a statistically insignificant trend toward a reduction in baseline DPFV (SMD: \u22120.09; 95% CI: \u22120.38, 0.19; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.52) compared to healthy controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Patients with NAFLD are at a higher risk of coronary microvascular dysfunction, as demonstrated by reduced CFRV and hyperemic DPFV. The presence of abnormal coronary flow reserve in patients with NAFLD provides insights into the higher rates of cardiovascular disease in these patients. Early aggressive targeted interventions for impaired coronary flow reserve in subjects with NAFLD may lead to improvement in clinical outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039499","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T09:10:59Z","timestamp":1730884259000},"page":"e39499","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: A pilot meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"given":"Hritvik","family":"Jain","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Pervez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debankur","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical College and Hospital, Kolkata, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Ali","family":"Raza","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Karachi Medical and Dental College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushood","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seth GS Medical College and KEM Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez M.","family":"Odat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Government Medical College and New Civil Hospital, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Daoud","family":"Tariq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Foundation University Medical College, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fox","sequence":"additional","affiliation":[{"name":"College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0282-0251","authenticated-orcid":false,"given":"Rukesh","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raheel","family":"Ahmed","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R2-20250505","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease.","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"Suppl 1","key":"R3-20250505","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease.","volume":"8","author":"Almeda-Vald\u00e9s","year":"2009","journal-title":"Ann Hepatol"},{"key":"R4-20250505","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.09090769","article-title":"Presence of coronary plaques in patients with nonalcoholic fatty liver disease.","volume":"254","author":"Assy","year":"2010","journal-title":"Radiology"},{"key":"R5-20250505","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1464-5491.2003.01068.x","article-title":"The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.","volume":"21","author":"Bonora","year":"2004","journal-title":"Diabet Med"},{"key":"R6-20250505","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"key":"R7-20250505","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"R8-20250505","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","article-title":"Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update.","volume":"21","author":"Athyros","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R9-20250505","doi-asserted-by":"crossref","first-page":"101643","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R10-20250505","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1161\/01.CIR.0000147540.88559.00","article-title":"Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.","volume":"110","author":"Juonala","year":"2004","journal-title":"Circulation"},{"key":"R11-20250505","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.0000112565.60887.1E","article-title":"Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study.","volume":"109","author":"Benjamin","year":"2004","journal-title":"Circulation"},{"key":"R12-20250505","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1445-5994.2007.01481.x","article-title":"Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.","volume":"38","author":"Senturk","year":"2008","journal-title":"Intern Med J"},{"key":"R13-20250505","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1148\/radiol.2019181793","article-title":"Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET\/CT.","volume":"291","author":"Vita","year":"2019","journal-title":"Radiology"},{"key":"R14-20250505","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.semnuclmed.2014.05.003","article-title":"Cardiac PET perfusion: prognosis, risk stratification, and clinical management.","volume":"44","author":"Dorbala","year":"2014","journal-title":"Semin Nucl Med"},{"key":"R15-20250505","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIRCULATIONAHA.111.050427","article-title":"Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.","volume":"124","author":"Murthy","year":"2011","journal-title":"Circulation"},{"key":"R16-20250505","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-7120-1-4","article-title":"Transthoracic doppler echocardiography \u2013 noninvasive diagnostic window for coronary flow reserve assessment.","volume":"1","author":"Dimitrow","year":"2003","journal-title":"Cardiovasc Ultrasound"},{"key":"R17-20250505","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ahj.2003.07.029","article-title":"Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries.","volume":"147","author":"Ragosta","year":"2004","journal-title":"Am Heart J"},{"key":"R18-20250505","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00004872-200303000-00030","article-title":"Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients.","volume":"21","author":"Rizzoni","year":"2003","journal-title":"J Hypertens"},{"key":"R19-20250505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.amjhyper.2006.06.017","article-title":"Coronary flow reserve in hypertensive patients with hypercholesterolemia and without coronary heart disease.","volume":"20","author":"Galderisi","year":"2007","journal-title":"Am J Hypertens"},{"key":"R20-20250505","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1291\/hypres.26.945","article-title":"Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease.","volume":"26","author":"Takiuchi","year":"2003","journal-title":"Hypertens Res"},{"key":"R21-20250505","first-page":"32","article-title":"C-Reactive protein to albumin ratio may be an inflammatory indicator for the coronary slow flow phenomenon.","volume":"3","author":"Ardahanli","year":"2023","journal-title":"Lokman Hekim Health Sci"},{"key":"R22-20250505","first-page":"47","article-title":"Left ventricular myocardial performance index and its relationship with presystolic wave in prediabetic patients.","volume":"1","author":"Akdo\u011fan","year":"2021","journal-title":"Lokman Hekim Health Sci"},{"key":"R23-20250505","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2010.01.049","article-title":"Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.","volume":"211","author":"Yilmaz","year":"2010","journal-title":"Atherosclerosis"},{"key":"R24-20250505","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"R25-20250505","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R26-20250505","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R27-20250505","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1002\/sim.7372","article-title":"Measuring the statistical validity of summary meta-analysis and meta-regression results for use in clinical practice.","volume":"36","author":"Willis","year":"2017","journal-title":"Stat Med"},{"key":"R28-20250505","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1253\/circj.CJ-11-1487","article-title":"Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging.","volume":"76","author":"Nakamori","year":"2012","journal-title":"Circ J"},{"key":"R29-20250505","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4318\/tjg.2012.0489","article-title":"Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease.","volume":"23","author":"Pinarba\u015fi","year":"2012","journal-title":"Turk J Gastroenterol"},{"key":"R30-20250505","doi-asserted-by":"crossref","first-page":"20406223221122478","DOI":"10.1177\/20406223221122478","article-title":"Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank.","volume":"13","author":"Ma","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"R31-20250505","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease.","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"R32-20250505","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis.","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"R33-20250505","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","article-title":"A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease.","volume":"20","author":"Toh","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R34-20250505","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association.","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-20250505","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.cpcardiol.2024.102569","article-title":"Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: a comprehensive meta-analysis.","volume":"49","author":"Nso","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R36-20250505","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"R37-20250505","doi-asserted-by":"crossref","first-page":"d6891","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.","volume":"343","author":"Lazo","year":"2011","journal-title":"BMJ"},{"key":"R38-20250505","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/GME.0000000000000503","article-title":"Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women.","volume":"22","author":"Kim","year":"2015","journal-title":"Menopause"},{"key":"R39-20250505","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cld.2017.08.004","article-title":"Diagnosis and evaluation of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography.","volume":"22","author":"Tsai","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R40-20250505","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R41-20250505","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/01.mcg.0000225668.53673.e6","article-title":"Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.","volume":"40","author":"Goland","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R42-20250505","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep4.1387","article-title":"Mortality risk detected by atherosclerotic cardiovascular disease score in patients with nonalcoholic fatty liver disease.","volume":"3","author":"Golabi","year":"2019","journal-title":"Hepatol Commun"},{"key":"R43-20250505","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/dsi23-0013","article-title":"Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care.","volume":"37","author":"Nogueira","year":"2024","journal-title":"Diabetes Spectr"},{"key":"R44-20250505","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3390\/diagnostics13040614","article-title":"The link between NAFLD and metabolic syndrome.","volume":"13","author":"Radu","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R45-20250505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-020-01166-6","article-title":"Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.","volume":"19","author":"Guembe","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R46-20250505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1467-789X.2004.00126.x","article-title":"Hepatic steatosis in obese patients: clinical aspects and prognostic significance.","volume":"5","author":"Festi","year":"2004","journal-title":"Obes Rev"},{"key":"R47-20250505","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.CIR.62.2.212","article-title":"Report of the American society of echocardiography committee on nomenclature and standards in two-dimensional echocardiography.","volume":"62","author":"Henry","year":"1980","journal-title":"Circulation"},{"key":"R48-20250505","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R49-20250505","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-024-05556-x","article-title":"Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.","author":"Kaleta","year":"2024","journal-title":"Rheumatol Int"},{"key":"R50-20250505","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.103.8.1109","article-title":"Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve.","volume":"103","author":"B\u00f8ttcher","year":"2001","journal-title":"Circulation"},{"key":"R51-20250505","doi-asserted-by":"crossref","first-page":"26805","DOI":"10.1038\/srep26805","article-title":"Nonalcoholic fatty liver disease is associated with increased carotid intima-media thickness in type 1 diabetic patients.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"R52-20250505","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2337\/dc06-0135","article-title":"Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.","volume":"29","author":"Targher","year":"2006","journal-title":"Diabetes Care"},{"key":"R53-20250505","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03349177","article-title":"Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.","volume":"29","author":"Targher","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"R54-20250505","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10620-007-9998-7","article-title":"Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease.","volume":"53","author":"Aygun","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R55-20250505","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study.","volume":"25","author":"Brea","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R56-20250505","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1475-097X.2008.00794.x","article-title":"Assessment of coronary blood flow and the reactivity of the microcirculation non-invasively with transthoracic echocardiography.","volume":"28","author":"Kiviniemi","year":"2008","journal-title":"Clin Physiol Funct Imaging"},{"key":"R57-20250505","doi-asserted-by":"crossref","first-page":"e006427","DOI":"10.1161\/CIRCIMAGING.117.006427","article-title":"Quantitative assessment of coronary microvascular function: dynamic single-photon emission computed tomography, positron emission tomography, ultrasound, computed tomography, and magnetic resonance imaging.","volume":"10","author":"Feher","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"R58-20250505","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2214\/ajr.185.1.01850095","article-title":"Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy.","volume":"185","author":"Sakuma","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"R59-20250505","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/01.CIR.0000138106.84335.62","article-title":"Myocardial first-pass perfusion magnetic resonance imaging: a multicenter dose-ranging study.","volume":"110","author":"Wolff","year":"2004","journal-title":"Circulation"},{"key":"R60-20250505","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1253\/circj.CJ-09-0855","article-title":"Vegetation with ventricular septal defect detected by cardiac magnetic resonance imaging.","volume":"74","author":"Kurita","year":"2010","journal-title":"Circ J"},{"key":"R61-20250505","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/eurheartj\/ehn521","article-title":"Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire.","volume":"30","author":"Kurita","year":"2009","journal-title":"Eur Heart J"},{"key":"R62-20250505","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/hr.2010.140","article-title":"Hypertension impairs myocardial blood perfusion reserve in subjects without regional myocardial ischemia.","volume":"33","author":"Nakajima","year":"2010","journal-title":"Hypertens Res"},{"key":"R63-20250505","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1161\/01.CIR.0000103625.15944.62","article-title":"Noninvasive evaluation of coronary reperfusion by transthoracic Doppler echocardiography in patients with anterior acute myocardial infarction before coronary intervention.","volume":"108","author":"Lee","year":"2003","journal-title":"Circulation"},{"key":"R64-20250505","doi-asserted-by":"crossref","first-page":"c200","DOI":"10.1159\/000087579","article-title":"Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study.","volume":"101","author":"Tok","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"R65-20250505","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.CIR.87.1.86","article-title":"Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels.","volume":"87","author":"Treasure","year":"1993","journal-title":"Circulation"},{"key":"R66-20250505","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.69.1.107","article-title":"Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.","volume":"69","author":"Brilla","year":"1991","journal-title":"Circ Res"},{"key":"R67-20250505","doi-asserted-by":"crossref","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","article-title":"Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.","volume":"291","author":"Lautam\u00e4ki","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R68-20250505","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jcmg.2016.10.024","article-title":"Pericardial, but not hepatic, fat by CT is associated with CV outcomes and structure: the multi-ethnic study of atherosclerosis.","volume":"10","author":"Shah","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"R69-20250505","first-page":"269","article-title":"Hepatic steatosis and vascular disease.","volume":"9","author":"Santoliquido","year":"2005","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R70-20250505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"key":"R71-20250505","first-page":"265","article-title":"Endothelial dysfunction and reactive oxygen species production in ischemia\/reperfusion and nitrate tolerance.","volume":"23","author":"Szocs","year":"2004","journal-title":"Gen Physiol Biophys"},{"key":"R72-20250505","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2009.06142.x","article-title":"Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?","volume":"25","author":"Ahishali","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R73-20250505","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.ATV.18.2.294","article-title":"Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries.","volume":"18","author":"Yokoyama","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R74-20250505","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/clc.4960290508","article-title":"Adiponectin produced in coronary circulation regulates coronary flow reserve in nondiabetic patients with angiographically normal coronary arteries.","volume":"29","author":"Date","year":"2006","journal-title":"Clin Cardiol"},{"key":"R75-20250505","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/HJR.0b013e32831f1b8a","article-title":"Association of serum adiponectin levels and coronary flow reserve in women with normal coronary angiography.","volume":"16","author":"Eroglu","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R76-20250505","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/MCG.0b013e31819e9048","article-title":"Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.","volume":"43","author":"Savvidou","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R77-20250505","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50044","article-title":"Vascular mediators in the injured liver.","volume":"37","author":"Rockey","year":"2003","journal-title":"Hepatology"},{"key":"R78-20250505","doi-asserted-by":"crossref","first-page":"96","DOI":"10.12997\/jla.2023.12.2.96","article-title":"Risk stratification of cardiovascular disease according to age groups in new prevention guidelines: a review.","volume":"12","author":"Kim","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"R79-20250505","doi-asserted-by":"crossref","first-page":"654","DOI":"10.46747\/cfp.6809654","article-title":"Approach to risk stratification of atherosclerotic cardiovascular disease.","volume":"68","author":"Esau","year":"2022","journal-title":"Can Fam Physician"},{"key":"R80-20250505","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2023.4520","article-title":"Risk prediction for atherosclerotic cardiovascular disease with and without race stratification.","volume":"9","author":"Ghosh","year":"2024","journal-title":"JAMA Cardiol"},{"key":"R81-20250505","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/eurheartj\/ehad579","article-title":"Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.","volume":"45","author":"Gould","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T20:02:08Z","timestamp":1746475328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":81,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039499","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]}}}